Novo Nordisk A/S (NYSE:NVO)

58.13
Delayed Data
As of 6:30pm ET
 -1.36 / -2.29%
Today’s Change
46.47
Today|||52-Week Range
64.82
+0.43%
Year-to-Date
5-Stock-Sampler Review-a-Palooza
Feb 26 / MotleyFool.com - Paid Partner Content
A Plan to Use Blockchain to Stop Counterfeit Drugs Moves Forward
Feb 21 / MotleyFool.com - Paid Partner Content
FDA Approves Eli Lilly's Trulicity to Reduce Cardiovascular Events in Type 2 Diabetes Patients
Feb 24 / MotleyFool.com - Paid Partner Content
Oscar Health Cuts Co-Pays on About 100 Drugs to $3
Feb 21 / MotleyFool.com - Paid Partner Content